Document is current
Any future updates will be listed below
-
Authors
McGrath, Mary
Weyand, Angela C. https://orcid.org/0000-0003-2595-8541
- License Information
-
More Information
Article History
Received: 16 January 2026
Accepted: 27 February 2026
First Online: 28 March 2026
Declarations
:
: Angela C. Weyand has acted as a consultant/participated in advisory boards for Takeda, Hemab, Sanofi, Seragene, Alnylam, and Genentech, received honoraria as a speaker for Octapharma and has received research funding from Sanofi, Hemab, Vega/Star, Genentech, and Spark Biomedical. Mary McGrath has nothing to disclose.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.
